Skip to content Skip to footer
A substantial takeover premium highlights the value of differentiated medicines, while Serina Therapeutics and Eupraxia Pharmaceuticals approach clinical milestones of their own. October 19, 2026 Biotechnology investors received a rather emphatic reminder Monday that pharmaceutical innovation can still command a premium, even…
Elon Musk’s pledge, accelerating AI infrastructure revenue and a widening semiconductor recovery offer investors a bullish counterpoint to a housing market stuck in hesitation. America’s next generation may receive its first stock certificate before its first driver’s license. Elon Musk said Monday…